Morgan Stanley’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55.7M Sell
345,245
-15,324
-4% -$2.47M ﹤0.01% 1818
2025
Q1
$61.3M Sell
360,569
-64,018
-15% -$10.9M ﹤0.01% 1631
2024
Q4
$70.6M Sell
424,587
-6,267
-1% -$1.04M ﹤0.01% 1519
2024
Q3
$74.1M Buy
430,854
+13,421
+3% +$2.31M 0.01% 1478
2024
Q2
$64.3M Sell
417,433
-49,891
-11% -$7.68M 0.01% 1512
2024
Q1
$71.9M Sell
467,324
-938,344
-67% -$144M 0.01% 1429
2023
Q4
$222M Buy
1,405,668
+758,541
+117% +$120M 0.01% 1086
2023
Q3
$94.7M Sell
647,127
-198,634
-23% -$29.1M 0.01% 1096
2023
Q2
$130M Buy
845,761
+69,331
+9% +$10.6M 0.01% 929
2023
Q1
$120M Buy
776,430
+31,660
+4% +$4.91M 0.01% 959
2022
Q4
$115M Buy
744,770
+126,555
+20% +$19.5M 0.01% 948
2022
Q3
$81.6M Sell
618,215
-5,163
-0.8% -$681K 0.01% 1015
2022
Q2
$84.5M Sell
623,378
-90,741
-13% -$12.3M 0.01% 1036
2022
Q1
$107M Sell
714,119
-103,199
-13% -$15.4M 0.01% 825
2021
Q4
$132M Sell
817,318
-26,008
-3% -$4.21M 0.02% 733
2021
Q3
$140M Sell
843,326
-112,678
-12% -$18.7M 0.02% 663
2021
Q2
$165M Buy
956,004
+17,344
+2% +$2.99M 0.02% 617
2021
Q1
$151M Sell
938,660
-63,995
-6% -$10.3M 0.02% 589
2020
Q4
$168M Sell
1,002,655
-6,986
-0.7% -$1.17M 0.03% 526
2020
Q3
$159M Sell
1,009,641
-78,915
-7% -$12.4M 0.03% 450
2020
Q2
$183M Buy
1,088,556
+253,255
+30% +$42.5M 0.04% 380
2020
Q1
$110M Buy
835,301
+12,807
+2% +$1.68M 0.03% 469
2019
Q4
$122M Sell
822,494
-89,182
-10% -$13.3M 0.03% 528
2019
Q3
$113M Sell
911,676
-600,990
-40% -$74.4M 0.03% 520
2019
Q2
$213M Sell
1,512,666
-146,233
-9% -$20.6M 0.06% 330
2019
Q1
$250M Buy
1,658,899
+104,362
+7% +$15.7M 0.07% 284
2018
Q4
$193M Buy
1,554,537
+6,793
+0.4% +$844K 0.06% 327
2018
Q3
$245M Buy
1,547,744
+574,869
+59% +$91.1M 0.06% 312
2018
Q2
$136M Buy
972,875
+51,791
+6% +$7.25M 0.04% 458
2018
Q1
$122M Buy
921,084
+72,044
+8% +$9.57M 0.03% 493
2017
Q4
$106M Sell
849,040
-86,852
-9% -$10.8M 0.03% 567
2017
Q3
$116M Buy
935,892
+47,020
+5% +$5.83M 0.03% 495
2017
Q2
$101M Buy
888,872
+29,347
+3% +$3.35M 0.03% 555
2017
Q1
$90.5M Buy
859,525
+51,976
+6% +$5.47M 0.03% 610
2016
Q4
$73.4M Buy
807,549
+268,093
+50% +$24.4M 0.02% 674
2016
Q3
$53.8M Buy
539,456
+43,645
+9% +$4.35M 0.02% 808
2016
Q2
$44.3M Buy
495,811
+11,489
+2% +$1.03M 0.02% 860
2016
Q1
$42.4M Sell
484,322
-2,326,325
-83% -$204M 0.02% 847
2015
Q4
$318M Buy
2,810,647
+213,991
+8% +$24.2M 0.12% 196
2015
Q3
$263M Sell
2,596,656
-61,180
-2% -$6.2M 0.1% 231
2015
Q2
$330M Sell
2,657,836
-32,169
-1% -$3.99M 0.11% 201
2015
Q1
$318M Buy
2,690,005
+237,552
+10% +$28.1M 0.12% 205
2014
Q4
$250M Buy
2,452,453
+218,997
+10% +$22.3M 0.09% 244
2014
Q3
$205M Buy
2,233,456
+127,567
+6% +$11.7M 0.08% 281
2014
Q2
$173M Sell
2,105,889
-138,222
-6% -$11.4M 0.07% 314
2014
Q1
$172M Buy
2,244,111
+124,136
+6% +$9.52M 0.07% 310
2013
Q4
$147M Buy
2,119,975
+257,736
+14% +$17.8M 0.06% 344
2013
Q3
$121M Buy
1,862,239
+755,521
+68% +$49M 0.06% 368
2013
Q2
$64.4M Buy
+1,106,718
New +$64.4M 0.03% 544